The operating platform for medtech commercialization.
Medtech Incubator gives early commercial medical technology companies the infrastructure, expertise, and industry relationships to launch and scale in the U.S. without building every function from scratch. One platform. One operating standard. Accountable to outcomes.
Clearance is a milestone. Adoption is the business.
Most medtech companies don't stall in the lab. They stall in the gap between regulatory clearance and repeatable revenue. That gap arrives all at once: distribution, logistics, clinical evidence, surgeon advocates, sales talent, contracting, and financial controls. Building each function in-house takes time and capital that early commercial companies rarely have, and getting any one of them wrong slows everything else.
We close that gap, so you get a proven commercial organization without spending the capital, or giving up the equity, to build one alone.
One platform. Every commercial function.
OPTIC unites nine specialized service companies under a single operating standard. Engage one capability or the entire platform. Either way, you work with operators who have done the job, under one plan, with one point of accountability.
Operations + Scale
Run the commercial engineAccess + Adoption
Build demand and accessOperator-led. Outcome-accountable.
Built for Commercialization
Every service we offer exists to move product into cases and revenue onto the books. We measure ourselves by outcomes, such as accounts opened, distributors producing, and surgeons using your product, not by reports delivered.
Expertise On Demand
Senior medtech operators across sales, marketing, clinical, operations, and finance, engaged when you need them. You get a full commercial organization's experience without carrying a full commercial organization's overhead.
Trusted Industry Relationships
Decades in orthopedics and spine mean we already know the distributors, surgeons, health systems, and strategic acquirers. Our network becomes your head start.
The need drives the solution. Never the other way around.
Every engagement follows the same disciplined path, so you always know what is being done, who owns it, and what it is meant to achieve.
Built for companies at the inflection point.
Deepest expertise in orthopedics, spine, and biologics, with capabilities that extend across surgical and procedural technologies.
Every recommendation we make is based on what is in the best interest of your business. If a solution doesn't create value, we won't propose it.
Selected milestones
- 2018Emerging Implant Technologies acquired by Johnson & Johnson Medical GmbH
- 2023Axolotl Biologix and Carmell Corporation transaction
- 2025Strategic partnership with BAAT Medical
- 2025Staysis Medical merger
- OngoingMultiple significant contract awards with major GPOs and IDNs
Ready to commercialize with confidence?
Tell us where you are and where you need to be. We'll show you the shortest credible path between the two.